UCN-01
Drug timelines are a Plus or Pro feature.
17 regulatory and trial events tracked for UCN-01, covering 2008-03-04 to 2016-06-23. Get the full timeline:
Most recent: Clinical Trial Update: UCN-01 and Topotecan in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer [Phase 1]